1.
Bernardini N, Skroza N, Rossi G, Mambrin A, Tolino E, Marraffa F, Caviglia M, Di Guardo A, Volpe S, Proietti I, Potenza C. Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema. Dermatol Reports [Internet]. 2022 Nov. 21 [cited 2024 May 18];14(4). Available from: https://www.pagepress.org/journals/dr/article/view/9447